Fibrolipoma of the mammary gland: features

Fibrolipoma of the mammary gland is a benign fatty tumor with a pronounced fibrous component. Essentially, it is a type of lipoma (fatty tumor) in which, in addition to fat lobules, a stromal (connective tissue) layer is visible. These tumors are most often localized in the subcutaneous fat of the breast, but can also be located deeper, in the parenchyma. They are usually soft, elastic, mobile, and painless. [1]

The key clinical question is whether this is truly a benign fatty lesion and whether there are signs of a rare fatty sarcoma (atypical lipomatous tumor/well-differentiated liposarcoma) or another "mimicking" condition, such as fat necrosis, hamartoma (fibroadenolipoma), or phyllodes tumor. The answer is provided by a combination of clinical examination, imaging, and, if necessary, needle biopsy. [2]

In most cases, fibrolipomas do not pose a cancer risk and do not require immediate removal. Indications for treatment include growth, discomfort, significant cosmetic defects, unfavorable imaging, or the patient's preference. Among the gentler methods, ultrasound-guided vacuum-assisted removal (incision-free, with good cosmetic results) is increasingly being used. [3]

It's important to distinguish fibrolipoma from hamartoma (fibroadenolipoma), a mixed "combination" of fatty, fibrous, and glandular tissue that follows different classification rules and is more common among benign tumors than "pure" lipomas. For patient-centered management, the ACR BI-RADS standards are used—a unified scale for the description and decision-making of mammography, ultrasound, and magnetic resonance imaging. [4]

ICD-10 and ICD-11 codes

Coding depends on the anatomy and morphology. If the lipoma/fibrolipoma is located in the skin or subcutaneous tissue of the chest wall, ICD-10 uses block D17 "Benign lipomatous tumor" with clarification of the location on the trunk (e.g., D17.1 - skin and subcutaneous tissue of the trunk). If the tumor is treated as a benign tumor of the mammary gland parenchyma, D24 "Benign tumor of the mammary gland" is used. The code selection is recorded in the documentation after clinical and radiological verification. [5]

In ICD-11, lipoma as a nosology is located in block 2E80.0 "Lipoma" with post-coordination of the anatomical expander (e.g., breast area), while 2F30 "Benign tumor of breast" excludes lipoma (coded separately). Hamartoma (fibroadenolipoma) has its own entry 2F30.5 "Fibroadenoma of breast"; other benign variants of the breast are listed in the same section. [6]

Table 1. How to code lipomas/fibrolipomas of the mammary gland

Clinical situation	ICD-10 (example)	ICD-11 (example)	Comment
Subcutaneous lipoma of the chest wall (chest area)	D17.1 (subcutaneous tissue of the trunk)	2E80.0 "Lipoma" + anatomical modifier (mammary gland)	Fatty tumor of the skin/SFC
A benign tumor of the breast parenchyma, commonly referred to as a lipoma	D24	2E80.0 + Anatomy Modifier	Some systems prefer D24; please provide justification
Hamartoma (fibroadenolipoma)	D24	2F30.5	Mixed tissue: adipose + glandular + fibrous
Suspected sarcoma - not confirmed	R codes / observation	-	Do not assign malignancy codes before morphology

Epidemiology

Lipoma is one of the most common benign tumors in the human body, but its exact prevalence in the mammary gland is difficult to estimate: publications note the paradox of "considered common, yet rare" due to underreporting and asymptomatic progression. Older clinical and pathological series cited a frequency of approximately 2.2% among mammary tumors, but current data are mixed. [7]

The peak age is 40-60 years. Lipomas ≥10 cm or weighing ≥1000 g are called "giant"; they are rare, but have been described, including isolated observations in the 50-60-year-old group. For most patients, the lesions are small and are discovered incidentally on screening mammography or ultrasound. [8]

Fibrolipomas, as a variant of lipoma, are not separately identified in general statistics; clinically and on imaging, they behave like lipomas and are most often benign findings that do not require immediate intervention. The most important thing is not to miss the extremely rare liposarcoma/atypical lipomatous tumor. [9]

Table 2. Epidemiological landmarks

Indicator	Range/Estimate	Source
The reported proportion of lipomas among breast tumors	~2% (historical data)	Li 2011 (review) [10]
Typical age	40-60 years old	Clinical series/reviews [11]
"Giant" lipomas	≥10 cm or ≥1000 g	Case reports/reviews [12]

Reasons

Fibrolipomas develop from mature adipose tissue with areas of pronounced fibrosis. A single trigger has not been proven: local trauma, microinflammation, and characteristics of the adipose tissue and stromal response are discussed. Hereditary syndromes for isolated breast lipomas are extremely rare. [13]

Sometimes a fibrolipoma is the result of the slow growth of an existing small fatty nodule due to fluctuations in body weight and hormonal levels, but a direct cause-and-effect relationship with reproductive hormones has not been established. As it grows, the growth may become noticeable during self-examination or screening. [14]

Risk factors

No reliable individual predictors have been identified for fibrolipomas specifically. As with lipomas in other areas, adults in the 4th to 6th decades of life are most often affected. A slight male predisposition has been described for lipomas in general, but data for the thoracic region are mixed. [15]

Indirect factors include local trauma/pressure (e.g., belts, sports equipment), and metabolic fluctuations; however, these are more observational associations than proven causes. The role of familial predisposition in isolated breast lipomas is minimal. [16]

Pathogenesis

Microscopically, fibrolipoma is composed of mature adipocytes separated by prominent fibrous septa; cellular atypia is absent. It is the predominance of fibrosis that gives the nodule a denser consistency and sometimes a less "ideal" fatty appearance on magnetic resonance imaging. This explains why biopsy is used to rule out sarcoma in questionable cases. [17]

On imaging, a lipoma/fibrolipoma typically appears as a well-defined, fat-dense mass (mammography), a hyperechoic or isoechoic oval mass with thin septa (ultrasound), and on magnetic resonance imaging (MRI) as a fat-like signal with "pure" suppression on fat-suppressed sequences. Thick/irregular septa, nodular, non-fatty areas, and pronounced contrast enhancement are a reason to exclude an atypical lipomatous tumor/liposarcoma. [18]

Symptoms

Fibrolipomas are most often asymptomatic and discovered incidentally. If palpated, the nodule is typically soft, elastic, mobile, and painless. Pain may occur with large sizes, skin tension, or compression of adjacent structures. [19]

Cosmetic complaints (asymmetry, "lump") are the most common reason for consultation. Skin redness, "orange peel" appearance, nipple retraction, and "fixation" to the skin/muscle are atypical for lipoma and require a more cautious approach. [20]

Forms and stages

Lipomas do not have a staging system, as in oncology. By location, they are classified as subcutaneous or deeper (in the parenchyma). By size, they are classified as small or "giant." By structure, they are classified as "pure" lipomas and variant lipomas (fibrolipoma, angiolipoma, chondroid lipoma, etc.)—the latter often pose diagnostic difficulties and require morphological confirmation. [21]

It is useful to distinguish fibrolipoma from hamartoma (fibroadenolipoma), where glandular tissue is attached to fat: on mammography, the classic “breast within a breast” (glandular-fatty mixture in a capsule) appears, but the tactics are different. [22]

Complications and consequences

Fibrolipoma itself causes few complications. The main risks are cosmetic defects, psychological anxiety, and diagnostic uncertainty. Rapid changes, atypical images, or very large sizes raise the question of excluding liposarcoma; delaying verification increases stress and may delay necessary treatment. [23]

Recurrences after removal are rare; they are more common with incomplete excision or with "atypical" lipoma variants. The cosmetic and satisfaction profile is better with minimally invasive methods compared to open surgery. [24]

Table 3. Red flags not typical for lipoma

Sign	What could it mean?	Action
Rapid growth, pain, stiffness, fixation	Atypical lipomatous tumor/other sarcoma	Urgent imaging + core biopsy
Irregular thick septa, nodular non-fatty areas on MRI	Risk of sarcoma	Biopsy/oncology routing
Skin/nipple retraction, skin symptoms	Not a lipoma	Diagnostic algorithm for breast tumors

When to see a doctor

A reason to visit is any new palpable nodule, especially if it grows, changes shape, differs in consistency from a "soft lump," or is accompanied by skin changes. It is impossible to independently distinguish a lipoma from other nodules. [25]

If the lesion resembles a "soft ball" and is discovered by chance, a routine examination is sufficient: the doctor will assess the need for imaging and the appropriate strategy (observation/removal). If cosmetic discomfort is present, minimally invasive removal is considered. [26]

Diagnostics

The initial step is a clinical and physical examination. The choice of initial imaging depends on the age and clinical situation: in patients <30 years of age with a palpable nodule, ultrasound is used; in patients ≥40 years of age, diagnostic mammography (or tomosynthesis mammography) with targeted ultrasound is performed. If mammography is negative and the nodule persists, ultrasound is performed; magnetic resonance imaging is not the next "default" method. [27]

If the imaging is typical for a lipoma (pure fat on mammography/MRI, "fatty" signal with fat suppression, an oval hyperechoic structure with thin septa on ultrasound, no suspicious features), observation is acceptable. If there is any ambiguity, an image-guided core biopsy is performed. [28]

The image report is generated according to BI-RADS and linked to the tactics: BI-RADS 2 - benign (observation), BI-RADS 3 - probably benign (short-term follow-up), BI-RADS 4-5 - biopsy. A standardized scale is the key to uniform decisions. [29]

Table 4. Step-by-step diagnostic route

Step	What are we doing?	Target	The next step
1	Inspection and palpation	Confirm "node"	Visualization by age
2	Ultrasound / DM/TM (≥40 years) ± MRI in case of controversial signs	Clarify the nature	BI-RADS 2-3 observation / 4-5 biopsy
3	Core biopsy in case of doubt	Morphology	Decision to remove
4	Discussion of options	Watch or delete	Individually

Table 5. Typical and warning signs in images

Method	“For” lipoma/fibrolipoma	Signs of alertness
Mammography	A distinct fatty nodule, sometimes a capsule	Low-fat, dense components
Ultrasound	Oval/round, hyper-/isoechoic, thin septa	Uneven contours, pronounced vascularization
MRI	Fat signal with complete suppression	Thick septa, nodes, intense contrast

Differential diagnosis

Hamartoma (fibroadenolipoma). Contains a mixture of fat and glandular tissue; on mammography, it appears "breast-within-a-breast." The treatment approach is closer to that of benign breast parenchyma tumors. [30]

Fat necrosis. May mimic a tumor, producing calcifications and retractions; diagnosis is based on comparison with trauma/surgery, characteristic MRI findings, or biopsy.

Atypical lipomatous tumor/liposarcoma. Rarely found in the breast; suspected due to rapid growth, "hardness," and thickened septa/nodes on MRI. Core biopsy and oncologic consultation are required. [31]

Phyllodes tumor, fibroadenoma. Dense solid formations without "pure" fat; managed according to the protocols for fibroepithelial lesions. [32]

Table 6. What most often “pretends” to be fibrolipoma

Option	What is similar?	How to distinguish	Tactics
Hamartoma	Fat in the composition of the node	Breast-within-a-breast, glandular inclusions	Individually, more often observation/excision as indicated
Fat necrosis	Fatty nature	History of trauma, typical calcifications	According to data; often observed
Liposarcoma	"Fat" node	Thick septa/nodes on MRI, growth	Biopsy, oncologic routing
Phyllodes/fibroadenoma	Palpable node	There is no "pure" fat	According to fibroepithelial protocols

Treatment

Observation. If the lipoma/fibrolipoma has typical features (BI-RADS 2), is small in size, and is uncomplicated, this is the default choice. Follow-up is usually not required more frequently than routine unless there is progress. For BI-RADS 3, short-term follow-up (usually 6-12 months) is recommended according to local protocol. [33]

Minimally invasive removal (vacuum-assisted excision, ultrasound guidance). Indicated in cases of cosmetic discomfort, growth in size, patient concerns, or the patient's desire. This method ensures high completeness of removal of nodes up to ~5 cm, low trauma, and good cosmetic outcomes; hematoma is a common but manageable complication. [34]

Open surgery. Indicated for giant lipomas, failure of minimally invasive techniques, complex anatomy, or suspected sarcoma. Cosmetic guidelines (incision placement, contour maintenance) and complete removal of the capsule are important to reduce the risk of recurrence. [35]

What not to do. Do not delay a biopsy if there are alarming signs on MRI/ultrasound; do not treat an "unclear" growing nodule without morphological verification; do not promise "resorption" of large lipomas - this is extremely unlikely. [36]

Table 7. Comparison of treatment approaches

Parameter	Observation	Vacuum excision (ultrasound-guided)	Open excision
Traumaticity	Minimum	Low	Medium/high
Cosmetics	Excellent	Excellent	Depends on the cut/volume
Completeness of removal	-	High (for nodes up to ~5 cm)	High
Indications	No complaints, typical appearance	Complaints, growth, patient's desire	Giant/complex/suspicious

Prevention

There is no specific prevention. General recommendations include weight control, physical activity, breast protection, and proper selection of underwear/sports equipment. It is important to know your "normal" sensations and seek medical attention if a new lump appears or changes in shape. (The evidence base for the impact of lifestyle on lipomas is limited.) [37]

Forecast

The prognosis for fibrolipoma is favorable. Most nodules are consistently benign, and complications are rare. After removal, the cosmetic result is generally good, especially with minimally invasive techniques. The risk of malignant transformation of the lipoma itself is extremely low; caution is not associated with transformation, but rather with the goal of not missing a rare sarcoma that "resembles" a lipoma. [38]

FAQ

Does it necessarily need to be removed?
No. If the symptoms are typical and there is no discomfort, a fibrolipoma can be observed. Removal is discussed based on growth, cosmetic reasons, concerns, or your preference. [39]

Is it possible to "dissolve" or "resolve" a lipoma?
There are no reliable methods. Ointments and physical therapy are ineffective. The only viable options are observation, ultrasound-guided vacuum excision, or open surgery when indicated. [40]

When is a biopsy necessary?
When there are concerns based on imaging (thick septa, non-fatty nodules, rapid growth), there is incomplete concordance between clinical and visualization data, or the physician still has questions. An image-guided core biopsy is performed. [41]

What's the difference between a fibrolipoma and a hamartoma?
A fibrolipoma is fat and marked fibrosis; a hamartoma is a "cocktail" of fat and glandular tissue. On mammography, a hamartoma produces a characteristic "breast within a breast" appearance, and the treatment approach is different. [42]